These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

530 related items for PubMed ID: 33982338

  • 1. Long-term effect of human mini-dystrophin in transgenic mdx mice improves muscle physiological function.
    Chu X, Li J, Qiao C, Wang J, Wang Y, Jiang XC, You H, Xiao X, Wang B.
    FASEB J; 2021 Jun; 35(6):e21628. PubMed ID: 33982338
    [Abstract] [Full Text] [Related]

  • 2. Dual AAV therapy ameliorates exercise-induced muscle injury and functional ischemia in murine models of Duchenne muscular dystrophy.
    Zhang Y, Yue Y, Li L, Hakim CH, Zhang K, Thomas GD, Duan D.
    Hum Mol Genet; 2013 Sep 15; 22(18):3720-9. PubMed ID: 23681067
    [Abstract] [Full Text] [Related]

  • 3. [Gene therapy for muscular dystrophy].
    Takeda S.
    No To Hattatsu; 2004 Mar 15; 36(2):117-23. PubMed ID: 15031985
    [Abstract] [Full Text] [Related]

  • 4. Mdx mice inducibly expressing dystrophin provide insights into the potential of gene therapy for duchenne muscular dystrophy.
    Ahmad A, Brinson M, Hodges BL, Chamberlain JS, Amalfitano A.
    Hum Mol Genet; 2000 Oct 12; 9(17):2507-15. PubMed ID: 11030755
    [Abstract] [Full Text] [Related]

  • 5. Delivery of AAV2/9-microdystrophin genes incorporating helix 1 of the coiled-coil motif in the C-terminal domain of dystrophin improves muscle pathology and restores the level of α1-syntrophin and α-dystrobrevin in skeletal muscles of mdx mice.
    Koo T, Malerba A, Athanasopoulos T, Trollet C, Boldrin L, Ferry A, Popplewell L, Foster H, Foster K, Dickson G.
    Hum Gene Ther; 2011 Nov 12; 22(11):1379-88. PubMed ID: 21453126
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Stable micro-dystrophin gene transfer using an integrating adeno-retroviral hybrid vector ameliorates the dystrophic pathology in mdx mouse muscle.
    Roberts ML, Wells DJ, Graham IR, Fabb SA, Hill VJ, Duisit G, Yuasa K, Takeda S, Cosset FL, Dickson G.
    Hum Mol Genet; 2002 Jul 15; 11(15):1719-30. PubMed ID: 12095914
    [Abstract] [Full Text] [Related]

  • 9. Differential effects of dystrophin and utrophin gene transfer in immunocompetent muscular dystrophy (mdx) mice.
    Ebihara S, Guibinga GH, Gilbert R, Nalbantoglu J, Massie B, Karpati G, Petrof BJ.
    Physiol Genomics; 2000 Sep 08; 3(3):133-44. PubMed ID: 11015608
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. AAV vector-mediated microdystrophin expression in a relatively small percentage of mdx myofibers improved the mdx phenotype.
    Yoshimura M, Sakamoto M, Ikemoto M, Mochizuki Y, Yuasa K, Miyagoe-Suzuki Y, Takeda S.
    Mol Ther; 2004 Nov 08; 10(5):821-8. PubMed ID: 15509500
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.